Connecting the market of activist investors.
Discover activist campaigns or launch your own with the platform trusted by investors.
Past performance does not guarantee future results.
Active Campaigns
Discover institutional activist investment opportunities
Solventum - A Separation Crisis
Activist campaign demanding Solventum restore performance to historical levels after an alarming post-spin decline. Trian argues that despite being 3M's best-performing division with consistent 3-4% organic growth at 26% EBIT margins, Solventum now delivers near-zero growth at 20% margins—making it one of the worst-performing spins in a decade. The campaign calls for an ambitious Long Range Plan that reverses declines through increased growth investments funded by overhead savings, portfolio simplification of non-core businesses (Dental, Health Info Systems, Purification & Filtration), and disciplined capital allocation including deleveraging and eventual shareholder returns.
Elliott vs. Southwest Airlines - Operational Excellence Campaign
Elliott acquired a $1.9 billion stake (~10%) in Southwest Airlines, pushing for leadership changes and operational improvements. Successfully secured Chairman Gary Kelly's resignation effective 2025 and obtained 5 board seats in settlement agreement.
Elliott vs. Texas Instruments - FCF Optimization
Elliott acquired a $2.5 billion position in Texas Instruments, engaging constructively to achieve $9 free cash flow per share target by 2026 through operational improvements and capital allocation optimization.
Elliott vs. BP - Energy Focus Strategy
Elliott acquired a £3.8 billion stake (5%) in BP, pushing for increased oil and gas production over renewables focus to maximize shareholder returns during the energy transition.
Ananym Capital Management vs Henry Schein
Ananym Capital Management launched an activist campaign against Henry Schein in November 2024, calling for board refreshment, leadership succession planning, cost reduction measures, and consideration of strategic alternatives including the potential sale of the medical distribution business. The campaign centers on concerns about CEO Stanley Bergman's succession planning (age 75, 40+ year tenure), excessive costs, and undervaluation of the stock.
From Discovery to Campaign Management
Whether you're discovering opportunities or managing campaigns, access institutional-grade tools with enterprise security and compliance
Browse unlimited campaigns
Campaign Management
Comprehensive suite of tools designed for institutional investors.
Trusted by Leading Institutions
Enterprise-grade security, compliance, and performance
Enterprise Security
Bank-level security protocols with institutional data encryption
Regulatory Compliance
Automated SEC filing generation and compliance monitoring
Professional Analytics
Advanced reporting and performance tracking of campaigns